Related Experiment Videos
Carcinoma-associated dermatomyositis responding to plasmapheresis
Clinical and Experimental Dermatology
|July 1, 1989
Summary
Severe dermatomyositis linked to cancer improved rapidly with plasmapheresis. This treatment offers a new option for refractory cases unresponsive to standard therapies.
Area of Science:
- Dermatology
- Oncology
- Immunology
Background:
- Carcinoma-associated dermatomyositis is a rare paraneoplastic syndrome.
- Treatment resistance is common with conventional therapies like steroids and immunosuppressants.
Observation:
- A patient with severe dermatomyositis and advanced carcinoma showed no improvement with standard treatments.
- The patient experienced significant clinical improvement within 48 hours of undergoing plasmapheresis.
Findings:
- This case represents the first reported instance of dermatomyositis associated with advanced carcinoma responding to plasmapheresis.
- Plasmapheresis demonstrated efficacy in a refractory case of dermatomyositis.
Implications:
- Plasmapheresis may be a valuable therapeutic option for refractory dermatomyositis, particularly when associated with malignancy.
- Further research is warranted to explore the role of plasmapheresis in managing paraneoplastic autoimmune conditions.